Forschung & Innovation
Publikationen
HDAC inhibitors in liver cancer: which route to take?
PMU Autor*innen
Tobias Kiesslich, Daniel Neureiter
Alle Autor*innen
Tobias Kiesslich, Daniel Neureiter
Fachzeitschrift
Expert Review of Gastroenterology & Hepatology
Kurzfassung
Keywords
THERAPY, HEPATOCELLULAR-CARCINOMA, CELL-DEATH, HISTONE DEACETYLASES, PANOBINOSTAT